维替泊芬相关论文
目的 研究维替泊芬（verteporfin，VP）对肺纤维化小鼠的治疗作用及其机制。方法给予C57BL/6小鼠气管内注射博来霉素（bleomycin，BLM）建立肺......
本研究设计了一种主动稳定包载维替泊芬（verteporfin, BPD）的新生血管及肿瘤靶向阳离子脂质体（cationic liposome with drug active-l......
紫杉醇是目前抗肿瘤化疗药物中最有效的之一。然而,肿瘤细胞的多药耐药性依旧是阻碍紫杉醇有效治疗癌症的最主要因素。导致紫杉醇......
目的 制备细胞外囊泡(EVs)共载体系,以协同递送肿瘤坏死因子相关凋亡诱导配体(TRAIL)/维替泊芬(VPF)组合用于诱导口腔鳞癌细胞凋亡......
[目的]破骨细胞是能够降解骨质的唯一细胞，在骨骼系统疾病如骨质疏松的发病过程中扮演着重要角色.破骨细胞的分化及功能行使依赖于......
目的探讨维替泊芬(VP)对异丙肾上腺素(ISO)诱导的小鼠心肌纤维化是否有抑制作用及对心功能的影响。方法6周龄C57BL/6小鼠(购自中山......
目的探讨半剂量维替泊芬光动力疗法（photodynamic therapy，PDT）治疗中心性浆液性脉络膜视网膜病变（central serous chorioretinopathy，C......
目的比较1/3剂量与半剂量光动力疗法（photodynamic therapy，PDT）治疗慢性中心性浆液性脉络膜视网膜病变（central serous chorioretinap......
目的 探讨1/3剂量维替泊芬光动力疗法治疗急性中心性浆液性脉络膜视网膜病变(CSC)的远期疗效.方法 临床病例对照研究.对2009年1月......
目的 探讨1/3剂量维替泊芬光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变(CSC)的远期疗效.方法 结合患者病史和眼底检查、光学......
中心性浆液性脉络膜视网膜病变(CSC)在临床上仍缺乏特效性药物,多以热激光治疗为主.它虽可缩短病程,但对远期视力的提高没有明显效......
目的:基于维替泊芬的光动力疗法治疗局部晚期胰腺癌,旨在检测胰腺癌细胞AsPC-1和BxPC-3原位异种移植胰腺肿瘤小鼠中维替泊芬随时间......
A 19-year-old man presented with blurred vision in the right eye,which was diagnosed as a circumscribed choroidal hemang......
...
目的探讨TAZ蛋白在血管紧张素Ⅱ高血压引起的血管伤中的作用。方法18只雄性C57BL/6小鼠随机分成三组:正常对照组、AngⅡ高血压组、......
我们在中山大学中山眼科中心进修期间,全程参与用维替泊芬进行光动力学治疗(photodynamic therapy,PDT)湿性型黄斑病变10例,年龄最......
维速达尔(Visudyne,注射用维替泊芬)(图1)是诺华公司研制的一种来源于卟啉的第二代光敏药物.应用维速达尔的光动力疗法是治疗脉络......
目的探讨1/3剂量维替泊芬光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变（CSC）的疗效。方法选择2013年2月至2014年10月经眼底检查......
目的:报道维替泊芬治疗脉络膜骨瘤伴发的中心凹下脉络膜新生血管(CNV)1例.方法:介入式个案报道结果:1例患者,32岁,确诊为右眼脉络......
目的观察半剂量维替泊芬光动力疗法(PDT)和577 nm阈值下微脉冲激光(SML)治疗慢性中心性浆液性脉络膜视网膜病变(chronic central s......
肿瘤乏氧的微环境使光动力治疗的疗效降低,抑制肿瘤细胞自身呼吸耗氧比增加氧供给更能有效地克服肿瘤乏氧,提高光动力治疗疗效.为......
目的:膀胱癌在我国是泌尿生殖系统中发病率和死亡率排名第一的恶性肿瘤,具有很高的复发率,5年复发率接近50%,因此,膀胱癌成为国内......
Objective To evaluate the safety, effect on visual function, and fluorescein a ngiographic appearance of subfoveal choro......
Purpose The aim of this study was to describe the clinical and angiographic response of squamo us cell carcinoma (SCC)of......
Aim: To evaluate short term safety of an enhanced photodynamic therapy (PDT) protocol with half dose verteporfin for tre......
Background: Choroidal neovascularisations (CNV) is themajor cause of significant visual loss in patients with angioid st......
To investigate image preferences after photodynamic therapy (PDT). Prospective, cross-sectional study. Seventeen patient......
Background: Photodynamic therapy is a relatively new modality for the treatment of subfoveal choroidal neovascularizatio......
Introduction: The aim of this study was to analyse 1-and 2-year outcomes aft er photodynamic therapy (PDT) in clinical r......
Aim: To determine if photodynamic therapy (PDT) outcomes are related to lesion size in patients with subfoveal predomina......
Purpose: To examine the 12- month results of a group of patients treated with combined photodynamic therapy (PDT)- with ......
目的:报道维替泊芬治疗脉络膜骨瘤伴发的中心凹下脉络膜新生血管(CNV)1例。方法:介入式个案报道结果:1例患者,32岁,确诊为右眼脉络......
Purpose: To investigate the effects of photodynamic therapy (PDT) on subfoveal choroidal neovascularization (CNV) in age......
To evaluatethe visual outcome of patients with myopic subfoveal choroidal neovascularization (CNV) given photodynamic th......
Objective To determine the efficacy of photodynamic ther-apy(PDT)with verteporfin as a treatment for s ymptomatic polypo......
PURPOSE: To report the results of repeated bilateral sequential photodynamic therapy (PDT) with verteporfin for sub-reti......
PURPOSE: To report the incidence of back pain after photodynamic therapy,which suggests methods for prevention that are ......
Purpose:To evaluate the anatomic-functional results and complications associated with the use of photodynamic therapy(PD......
Objective: To assess if posterior juxtascleral application of 40 mg triamcinolone acetonide (TA), given at the same time......
Aim: To evaluate the impact of verteporfin photodynamic therapy (PDT) on the induction of apoptosis in choroidal neovasc......
Objective:To determine whether data from patients with agerelated macular degeneration(AMD)assigned to the placebo group......
Purpose: To report the results of verteporfin photodynamic therapy (PDT) of extrafoveal predominantly classic choroidal ......
